| Brian Thomas Scully, MD | |
|
3841 Piper Street, Suite T100, Anchorage, AK 99508 | |
| (907) 561-3211 | |
| (907) 562-7547 |
| Full Name | Brian Thomas Scully |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 25 Years |
| Location | 3841 Piper Street, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841209368 | NPI | - | NPPES |
| 1016005 | Medicaid | AK | |
| I59556 | Other | AK | UPIN REGISTRY ERROR - UPIN LISTED AS I59556 |
| P00341374 | Other | AK | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 5859 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mat-su Regional Medical Center | Palmer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Heart Institute | 2668371469 | 57 |
News Archive
OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that it has been selected by Amarex, a Mid-Atlantic based Contract Research Organization (CRO) to provide eClinical solutions for an upcoming Phase III trial investigating the use of a medical device for wound healing.
This year's flu season has now been declared an epidemic, with a particularly dangerous strain that has hospitalized more than 3,700 people, according to the Centers for Disease Control and Prevention (CDC).
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Power Medical Interventions Inc. (PMI) for an aggregate consideration of approximately $65 million, including assumption of debt.
Health Enhancement Products, Inc. and Changing Times Vitamins today announced, they have mutually agreed to terminate their current distribution agreement, in which Changing Times Vitamins had acquired the exclusive rights to distribute ProAlgaZyme (PAZ).
› Verified 1 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467547265 PECOS PAC ID: 2163335746 Enrollment ID: O20031110000525 |
News Archive
OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that it has been selected by Amarex, a Mid-Atlantic based Contract Research Organization (CRO) to provide eClinical solutions for an upcoming Phase III trial investigating the use of a medical device for wound healing.
This year's flu season has now been declared an epidemic, with a particularly dangerous strain that has hospitalized more than 3,700 people, according to the Centers for Disease Control and Prevention (CDC).
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Power Medical Interventions Inc. (PMI) for an aggregate consideration of approximately $65 million, including assumption of debt.
Health Enhancement Products, Inc. and Changing Times Vitamins today announced, they have mutually agreed to terminate their current distribution agreement, in which Changing Times Vitamins had acquired the exclusive rights to distribute ProAlgaZyme (PAZ).
› Verified 1 days ago
| Entity Name | Alaska Heart Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992744114 PECOS PAC ID: 2668371469 Enrollment ID: O20031231000146 |
News Archive
OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that it has been selected by Amarex, a Mid-Atlantic based Contract Research Organization (CRO) to provide eClinical solutions for an upcoming Phase III trial investigating the use of a medical device for wound healing.
This year's flu season has now been declared an epidemic, with a particularly dangerous strain that has hospitalized more than 3,700 people, according to the Centers for Disease Control and Prevention (CDC).
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Power Medical Interventions Inc. (PMI) for an aggregate consideration of approximately $65 million, including assumption of debt.
Health Enhancement Products, Inc. and Changing Times Vitamins today announced, they have mutually agreed to terminate their current distribution agreement, in which Changing Times Vitamins had acquired the exclusive rights to distribute ProAlgaZyme (PAZ).
› Verified 1 days ago
| Entity Name | Mat Su Valley Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912950148 PECOS PAC ID: 5698686475 Enrollment ID: O20040123000583 |
News Archive
OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that it has been selected by Amarex, a Mid-Atlantic based Contract Research Organization (CRO) to provide eClinical solutions for an upcoming Phase III trial investigating the use of a medical device for wound healing.
This year's flu season has now been declared an epidemic, with a particularly dangerous strain that has hospitalized more than 3,700 people, according to the Centers for Disease Control and Prevention (CDC).
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Power Medical Interventions Inc. (PMI) for an aggregate consideration of approximately $65 million, including assumption of debt.
Health Enhancement Products, Inc. and Changing Times Vitamins today announced, they have mutually agreed to terminate their current distribution agreement, in which Changing Times Vitamins had acquired the exclusive rights to distribute ProAlgaZyme (PAZ).
› Verified 1 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952430902 PECOS PAC ID: 5799675120 Enrollment ID: O20040318000605 |
News Archive
OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that it has been selected by Amarex, a Mid-Atlantic based Contract Research Organization (CRO) to provide eClinical solutions for an upcoming Phase III trial investigating the use of a medical device for wound healing.
This year's flu season has now been declared an epidemic, with a particularly dangerous strain that has hospitalized more than 3,700 people, according to the Centers for Disease Control and Prevention (CDC).
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Power Medical Interventions Inc. (PMI) for an aggregate consideration of approximately $65 million, including assumption of debt.
Health Enhancement Products, Inc. and Changing Times Vitamins today announced, they have mutually agreed to terminate their current distribution agreement, in which Changing Times Vitamins had acquired the exclusive rights to distribute ProAlgaZyme (PAZ).
› Verified 1 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1013905660 PECOS PAC ID: 5799675120 Enrollment ID: O20041221000920 |
News Archive
OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that it has been selected by Amarex, a Mid-Atlantic based Contract Research Organization (CRO) to provide eClinical solutions for an upcoming Phase III trial investigating the use of a medical device for wound healing.
This year's flu season has now been declared an epidemic, with a particularly dangerous strain that has hospitalized more than 3,700 people, according to the Centers for Disease Control and Prevention (CDC).
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Power Medical Interventions Inc. (PMI) for an aggregate consideration of approximately $65 million, including assumption of debt.
Health Enhancement Products, Inc. and Changing Times Vitamins today announced, they have mutually agreed to terminate their current distribution agreement, in which Changing Times Vitamins had acquired the exclusive rights to distribute ProAlgaZyme (PAZ).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Thomas Scully, MD Po Box 200149, Anchorage, AK 99520-0149 Ph: (907) 561-3211 | Brian Thomas Scully, MD 3841 Piper Street, Suite T100, Anchorage, AK 99508 Ph: (907) 561-3211 |
News Archive
OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, announced today that it has been selected by Amarex, a Mid-Atlantic based Contract Research Organization (CRO) to provide eClinical solutions for an upcoming Phase III trial investigating the use of a medical device for wound healing.
This year's flu season has now been declared an epidemic, with a particularly dangerous strain that has hospitalized more than 3,700 people, according to the Centers for Disease Control and Prevention (CDC).
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of Power Medical Interventions Inc. (PMI) for an aggregate consideration of approximately $65 million, including assumption of debt.
Health Enhancement Products, Inc. and Changing Times Vitamins today announced, they have mutually agreed to terminate their current distribution agreement, in which Changing Times Vitamins had acquired the exclusive rights to distribute ProAlgaZyme (PAZ).
› Verified 1 days ago
Andrea Caballero, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3220 Providence Dr Ste E3-080, Anchorage, AK 99508 Phone: 907-375-8785 Fax: 907-375-8788 | |
Daryl M. Mcclendon, M.D., P.C. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3851 Piper Street, Suite U466, Anchorage, AK 99508 Phone: 907-569-1333 Fax: 907-569-1433 | |
Dr. Loretta Leih-sheng Lee, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4001 Dale St, Suite 210, Anchorage, AK 99508 Phone: 907-929-5880 Fax: 907-929-5882 | |
Dr. Richard Merle Farleigh, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4120 Laurel St, Suite 202, Anchorage, AK 99508 Phone: 907-561-4293 | |
Alexis Leandro Delgado, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Geronimo Sahagun, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2841 Debarr Road, Suite 50, Anchorage, AK 99508 Phone: 907-276-2811 Fax: 907-276-2810 | |
Dr. Tram Phuong Chu, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Suite B111, Anchorage, AK 99508 Phone: 907-212-7890 Fax: 907-212-2374 |